Cognitive Therapy for Recurrent Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

523

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Depression
Interventions
BEHAVIORAL

Continuation phase cognitive therapy

Continuation phase cognitive therapy included 10 sessions over 8 months.

DRUG

Continuation phase fluoxetine

The dosage of fluoxetine was increased to 40 mg over 8 months.

OTHER

Continuation phase pill placebo

The dosage of pill placebo was increased to 40 mg over 8 months.

BEHAVIORAL

Acute phase cognitive therapy

For the first 12 weeks, all participants received between 16 and 20 cognitive therapy sessions.

Trial Locations (2)

15213

University of Pittsburgh Medical Center Western Psychiatric Institute and Clinic, Pittsburgh

75390

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT00118404 - Cognitive Therapy for Recurrent Depression | Biotech Hunter | Biotech Hunter